© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | NEPH DBTC CKD MULT ECLIA ALG | Medium Descr | NEPHROLOGY DIABETIC CKD MULT ECLIA PLASMA ALG | Long Descr | Nephrology (diabetic chronic kidney disease [CKD]), multiplex electrochemiluminescent immunoassay (ECLIA) of soluble tumor necrosis factor receptor 1 (sTNFR1), soluble tumor necrosis receptor 2 (sTNFR2), and kidney injury molecule 1 (KIM-1) combined with clinical data, plasma, algorithm reported as risk for progressive decline in kidney function | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Note | First appearance of change in codebook. |
| 2024-04-01 | Note | Change to proprietary name. |
| 2024-01-01 | Added | First appearance in codebook. |
| 2023-10-01 | Added | Code added. |
Get instant expert-level medical coding assistance.